[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condbio:malignant-neoplasm-of-biliary-tract:claudin-18-isoform-a2":3},{"condition":4,"biomarker":5,"total":6,"trials":7},"Malignant neoplasm of biliary tract","Claudin-18 Isoform A2",3,[8,16,23],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT05458219","A First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors",[12],"Phase 1","RECRUITING","2026-08-26T02:17:42.501124Z","2026-05-05T02:43:29.294686Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT06219941","AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2",[20],"Phase 2","2026-08-26T02:15:37.042762Z","2026-05-05T02:43:27.246686Z",{"nct_id":24,"title":25,"phases":26,"status":28,"updated_at":29,"content_modified":30},"NCT06921928","Study for AZD4360 in Participants With Advanced Solid Tumours",[27],"Phase 1\u002FPhase 2","ACTIVE_NOT_RECRUITING","2026-08-03T03:01:15.394071Z","2026-04-29T02:57:57.154395Z"]